Patient. | Injection Site | Blood ml | PBMC1 | Monocyte-depleted1 | Adherent cells2 | Final A-LAK recovery3 | CD16+CD56+CD3+ % | CD16+CD56+CD3- % | Labeled4 cells/injection | Labeling efficiency |
---|---|---|---|---|---|---|---|---|---|---|
1 | i.a. | 160 | 1.2 × 108 | 8 × 107 | 6 × 106 | 5 × 108 | 56 | 13 | 5 × 108 | 58 |
 | i.v. | 160 | 2.8 × 108 | 1.5 × 108 | 5 × 106 | 1.2 × 109 | 59 | 14 | 5 × 108 | 56 |
2 | i.a. | 160 | 1.2 × 108 | 8 × 107 | 3.2 × 106 | 1.6 × 109 | 12 | 69 | 5 × 108 | 62 |
 | i.v. | 160 | 2.5 × 108 | 9 × 107 | 3.6 × 106 | 6 × 108 | 2 | 85 | 5 × 108 | 67 |
3 | i.a. | 160 | 1.3 × 108 | 5 × 107 | 1 × 106 | 6 × 108 | 10 | 60 | 5 × 108 | 55 |
 | i.v. | 160 | 1.3 × 108 | 8 × 107 | 5 × 106 | 2.3 × 109 | 12 | 69 | 5 × 108 | 42 |